<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Tolerance to ischemic brain injury is induced by several preconditioning stimuli, including <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> (LPS) </plain></SENT>
<SENT sid="1" pm="."><plain>A small dose of LPS given systemically confers ischemic protection in the brain, a process that appears to involve activation of an <z:mp ids='MP_0001845'>inflammatory response</z:mp> before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We postulated that LPS preconditioning modulates the cellular <z:mp ids='MP_0001845'>inflammatory response</z:mp> after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, resulting in neuroprotection </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Mice were treated with LPS (0.2 mg/kg) 48 hours before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induced by transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> was measured by 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining </plain></SENT>
<SENT sid="5" pm="."><plain>Microglia/macrophage responses after MCAO were assessed by immunofluorescence and flow cytometry </plain></SENT>
<SENT sid="6" pm="."><plain>The effect of MCAO on white blood cells in the brain and peripheral circulation was measured by flow cytometry 48 hours after MCAO </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: LPS preconditioning induced significant neuroprotection against MCAO </plain></SENT>
<SENT sid="8" pm="."><plain>Administration of low-dose LPS before MCAO prevented the cellular <z:mp ids='MP_0001845'>inflammatory response</z:mp> in the brain and blood </plain></SENT>
<SENT sid="9" pm="."><plain>Specifically, LPS preconditioning suppressed neutrophil infiltration into the brain and microglia/macrophage activation in the ischemic hemisphere, which was paralleled by suppressed monocyte activation in the peripheral blood </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: LPS preconditioning induces neuroprotection against ischemic brain injury in a mouse model of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>LPS preconditioning suppresses the cellular <z:mp ids='MP_0001845'>inflammatory response</z:mp> to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the brain and circulation </plain></SENT>
<SENT sid="12" pm="."><plain>Diminished activation of cellular <z:mp ids='MP_0001845'>inflammatory responses</z:mp> that ordinarily exacerbate ischemic injury may contribute to neuroprotection induced by LPS preconditioning </plain></SENT>
</text></document>